Optometry in 2024: What to Expect for the New Year
December 21, 2023. If optometry in 2024 is anything like what we’ve witnessed in 2023, it could prove to be a year filled with innovative therapies for dry eye disease (DED), legislative victories, and new ways of comanaging geographic atrophy (GA). While optometrists have many reasons to celebrate, some events may cloud what has, for the ...
Red Light Therapy Provides Myopia Control ... - Optometry Advisor
November 22, 2023. As optometrists struggle with the demand created by an emerging myopia epidemic, repeated low-level red light therapy may provide an alternative to contact lens wear or atropine treatment for slowing axial progression and spherical equivalent refraction (SER). While the treatment has yet to receive US Food and Drug ...
Choroidal Vascular Changes in Ortho-k Explain Slowed AL Growth ...
1 day ago · Choroidal vascular changes were noted in the ortho-k group, evidenced by significant increases in luminal area (0.033±0.059 mm 2 increase), stromal area (0.024±0.035 mm 2 increase), total choroidal area (0.058±0.087 mm 2 increase), and subfoveal choroidal thickness (8.9±17.4 μm increase) at the 3-month visit (P <.05 for all).
2023 Pipeline Drugs Show Promise for Treating Dry Eye Disease
Jan 20, 2023 · Dry eye disease (DED) is highly prevalent in the US, affecting approximately 6.8% of the population — more than 22 million people — with numbers expected to rise as the population ages 1.In addition to the disease’s detrimental impact on vision, productivity, and quality of life, patients with DED also experience higher rates of major depression and anxiety. 1 For years, optometrists ...
Lens-Based Myopia Control: Know When to Treat and Expect Results
Dec 15, 2023 · Treatments were decided based on the results of this data analysis and patients were monitored every 3 to 6 months for progression, which was defined as 0.25 D or greater myopia spherical equivalent progression (as assessed with cycloplegic autorefraction) or greater than 0.10 mm axial elongation in 6 months. Children who showed progression while on one treatment, received a change in treatment.
OCT-A Reveals Retinal Structural Changes in Bipolar Disorder
2 days ago · OCT-A analysis revealed significantly reduced total deep retinal vessel density, parafoveal area, perifoveal area, and inside disc vessel density of the radial peripapillary capillaries among individuals with bipolar disorder compared with control group participants (P ≤.014 for all), the report shows.Individuals with bipolar disorder also had significantly thinner macular thickness in the ...
Metformin for AMD Treatment - Optometry Advisor
5 days ago · Anti-vascular endothelial growth factor (VEGF) treatments have improved visual outcomes among patients with age-related macular degeneration (AMD) for more than a decade, and 2 new intravitreal drugs — pegcetacoplan and avacincaptad pegol — have even demonstrated an ability to slow geographic atrophy (GA). As the leading cause of irreversible central vision loss among individuals older ...
Approaches to Patient Care in Optometry - Optometry Advisor
October 4, 2024. An optometry student can learn a lot in a lab or clinical research setting, but their contact with patients will ultimately guide their clinical decision-making skills and shape their perspectives, according to Andrew Rixon, OD, FAAO, Diplomate (Glaucoma), this year’s recipient of the Vincent Ellerbrock Clinician Educator Award.
Progressive Lens Designs Can Affect Patient Experience
Jun 7, 2024 · Continuous education in progressive lens technology will serve as a cornerstone in diminishing progressive lens returns, elevating patient satisfaction, and ultimately fostering the success of practices dedicated to presbyopic eye care. For 128 million U.S. presbyopes, doctors of optometry can provide treatment options.
Myopia Management Experts Agree More Research is Needed
October 16, 2024. Myopia experts agree that current myopia management strategies are effective, but acknowledge the need for more evidence-based research to determine the best treatment approaches and when to discontinue them. Clinicians with myopia management expertise support publicly funding myopia control initiatives, but acknowledge that ...